Skip to main content
. Author manuscript; available in PMC: 2014 Jan 8.
Published in final edited form as: Kidney Int. 2011 Feb 9;79(10):10.1038/ki.2010.555. doi: 10.1038/ki.2010.555

Table 1.

a | Patient demographics (total cohort, n=528)
Characteristics
  Age (years), mean±s.d. 60 ± 17
  Female % (n) 39.8 (210)
  Weight (kg), mean±s.d. 80 ± 19
  APACHE II score, mean±s.d. 18 ± 6.4
  SOFA score, mean±s.d. 6.3 ±2.8
Primary diagnosis (%) (n)
  Abdominal aortic aneurysm rupture and repair 4.5 (24)
  Abdominal surgery or inflammation 10.2 (54)
  Burns 0.9 (5)
  Cardiac arrest or failure 11.9 (63)
  Cardiac surgery 17.8 (94)
  Collapse, cause unknown 0.6 (3)
  Neurological surgery, injury, or seizure or hemorrhage 14.0 (74)
  Other 0.6 (3)
  Pulmonary or thoracic surgery or failure 12.1 (64)
  Sepsis 19.1 (101)
  Trauma 8.1 (43)
Outcomes (%) (n)
  AKIN on entry 27.8 (147)
  AKIN48 15.5 (82)
  RIFLE24 5.1 (27)
  Dialysis within 7 days 3.6 (19)
  Died within 7 days 10.2 (54)
b | Urinary biomarker concentrations on entry
N Mean±s.d. Median (IQR) Min Max
GGT (Units/l)/mmol/l Cr 526 28 ±55 13 (7–25) 1.9 923
AP (Units/l)/mmol/l Cr 526 1.7 ± 4.1 0.89 (0.46–1.8) 0.00025 74.8
CysC (mg/l)/mmol/l Cr 522 0.40 ± 1.1 0.016 (0.001–0.17) 0.0001 9.3
NGAL (ng/ml)/mmol/l Cr 487 140 ±410 8.0 (2.5–41) 0.0001 3000
IL-18 (pg/ml)/mmol/l Cr 523 73 ± 340 0.001 (0.001–36)a 0.0001 3100
KIM-1 (pg/ml)/mmol/l Cr 524 300 ± 1400 86 (37–210) 0.56 2800

Abbreviations: AKI, acute kidney injury; AKIN48, AKI within 48 h; APACHE II, Acute Physiology and Chronic Health Evaluation; ICU, intensive care unit; SOFA, Sequential Organ Failure Assessment.

Table modified from the study by Endre et al., 2010.16

AKIN on entry: ≥0.3 mg/dl or ≥50% increase in plasma creatinine from baseline on entry to the ICU.

AKIN48: Not AKIN on entry and ≥0.3 mg/dl or ≥50% increase in plasma creatinine from baseline within ~48 h.

RIFLE24: Not AKIN on entry and X50% increase in plasma creatinine sustained for ≥24h within 7 days.

Abbreviations: AP, alkaline phosphatase; Cr, creatinine; CysC, cystatin C; GGT, γ-glutamyltranspeptidase; IL-18, interleukin-18; IQR, interquartile range; KIM-1, kidney injury molecule-1; NGAL, neutrophil-gelatinase-associated lipocalin.

a

See distribution in Figure 1.